Owens & Minor (OMI) Shares Sold by Macquarie Group Ltd.

Macquarie Group Ltd. decreased its stake in Owens & Minor (NYSE:OMI) by 96.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 50,900 shares of the company’s stock after selling 1,383,504 shares during the quarter. Macquarie Group Ltd. owned approximately 0.08% of Owens & Minor worth $961,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Mutual of America Capital Management LLC grew its position in shares of Owens & Minor by 5.2% in the fourth quarter. Mutual of America Capital Management LLC now owns 53,241 shares of the company’s stock valued at $1,005,000 after purchasing an additional 2,654 shares during the period. Janney Montgomery Scott LLC grew its position in shares of Owens & Minor by 30.1% in the third quarter. Janney Montgomery Scott LLC now owns 13,821 shares of the company’s stock valued at $404,000 after purchasing an additional 3,196 shares during the period. Vident Investment Advisory LLC grew its position in shares of Owens & Minor by 4.0% in the third quarter. Vident Investment Advisory LLC now owns 86,652 shares of the company’s stock valued at $2,530,000 after purchasing an additional 3,328 shares during the period. Teachers Advisors LLC grew its position in shares of Owens & Minor by 4.0% in the fourth quarter. Teachers Advisors LLC now owns 113,226 shares of the company’s stock valued at $2,138,000 after purchasing an additional 4,360 shares during the period. Finally, New Amsterdam Partners LLC NY grew its position in shares of Owens & Minor by 7.0% in the fourth quarter. New Amsterdam Partners LLC NY now owns 70,997 shares of the company’s stock valued at $1,340,000 after purchasing an additional 4,628 shares during the period. Institutional investors and hedge funds own 96.90% of the company’s stock.

How to Become a New Pot Stock Millionaire

OMI opened at $15.84 on Friday. The stock has a market cap of $975.03, a P/E ratio of 9.84, a price-to-earnings-growth ratio of 0.96 and a beta of 1.06. Owens & Minor has a twelve month low of $14.26 and a twelve month high of $34.97. The company has a current ratio of 1.67, a quick ratio of 0.91 and a debt-to-equity ratio of 0.89.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings results on Wednesday, February 14th. The company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.01. The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.34 billion. Owens & Minor had a net margin of 0.78% and a return on equity of 9.63%. Owens & Minor’s quarterly revenue was up .9% on a year-over-year basis. During the same period in the previous year, the business posted $0.52 earnings per share. equities analysts predict that Owens & Minor will post 2.06 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, March 30th. Investors of record on Thursday, March 15th were given a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, March 14th. This is a positive change from Owens & Minor’s previous quarterly dividend of $0.26. This represents a $1.04 dividend on an annualized basis and a yield of 6.57%. Owens & Minor’s payout ratio is presently 64.60%.

Several brokerages have recently issued reports on OMI. JPMorgan Chase reiterated an “underweight” rating and issued a $22.00 target price on shares of Owens & Minor in a research report on Tuesday, December 19th. Zacks Investment Research upgraded shares of Owens & Minor from a “strong sell” rating to a “hold” rating in a research report on Wednesday. Barclays assumed coverage on shares of Owens & Minor in a research report on Thursday, March 8th. They issued an “underweight” rating and a $16.00 target price on the stock. ValuEngine lowered shares of Owens & Minor from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. Finally, Bank of America assumed coverage on shares of Owens & Minor in a research report on Tuesday, February 27th. They set a “buy” rating and a $19.00 price target on the stock. Six analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $24.28.

TRADEMARK VIOLATION NOTICE: This news story was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3340173/owens-minor-omi-shares-sold-by-macquarie-group-ltd.html.

About Owens & Minor

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

James River Group  Given Coverage Optimism Score of 0.10
James River Group Given Coverage Optimism Score of 0.10
Morgan Stanley Raises M&T Bank  Price Target to $191.00
Morgan Stanley Raises M&T Bank Price Target to $191.00
Stifel Nicolaus Trims Johnson & Johnson  Target Price to $135.00
Stifel Nicolaus Trims Johnson & Johnson Target Price to $135.00
Celanese  PT Raised to $112.00 at Morgan Stanley
Celanese PT Raised to $112.00 at Morgan Stanley
Campbell Soup  Given a $43.00 Price Target by Piper Jaffray Analysts
Campbell Soup Given a $43.00 Price Target by Piper Jaffray Analysts
Kemper  Cut to “Hold” at Zacks Investment Research
Kemper Cut to “Hold” at Zacks Investment Research


Leave a Reply

© 2006-2018 Ticker Report. Google+.